Radio and PodcastLive Radio & PodcastsScience & Medicine
Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1
Dr. Saland summarizes the main findings from his study on "Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
About This Episode
Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1 is an episode from Clinical Journal of the American Society of Nephrology (CJASN) by Hal Nesbitt. Dr. Saland summarizes the main findings from his stu...
Podcast
This episode belongs to Clinical Journal of the American Society of Nephrology (CJASN).
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Mar 18, 2026, 00:03:54 long, audio available.
Related Episodes
Continue listening to more episodes from Clinical Journal of the American Society of Nephrology (CJASN).
A Target Trial Emulation of GLP1RA, SGLT2i or DPP4i as Add on Treatment in CKD
Jun 17, 2026 - 00:05:28
Total Kidney Volume and eGFR in Polycystic Kidney Disease
May 18, 2026 - 00:03:54
Proteomic Markers of Dietary Patterns and Chronic Kidney Disease
Apr 16, 2026 - 00:04:50
Finerenone and eGFR Slope
Feb 26, 2026 - 00:03:00
Dynamic Risk Prediction of Deceased Donor Kidney Transplant Failure
Feb 18, 2026 - 00:04:06
Early-Start vs. Late-Start Icodextrin in Pediatric Peritoneal Dialysis Patients
Dec 18, 2025 - 00:06:20
Comparative Effectiveness of Lubiprostone and Stool Softeners in CKD
Oct 28, 2025 - 00:03:53